The AHA joined by the Association of American Medical Colleges and America’s Essential Hospitals today will urge a federal court to prevent the Department of Health and Human Services from reducing Medicare payments under the 340B drug savings program by nearly 30% effective Jan. 1. In a brief to be filed today in reply to the agency’s motion to dismiss their lawsuit challenging the reduction, the hospital groups say the payment cut “far exceeds” HHS’s authority to adjust the reimbursement rate and warrants a preliminary injunction to prevent “imminent” and “actual” harm to their members. Thirty-two state and regional hospital associations also today will urge the court in a friend-of-the-court brief to grant the preliminary injunction, arguing that the estimated $1.6 billion cut “will have devastating consequences for safety-net providers and the millions of patients they serve.”

Related News Articles

Headline
The Campaign for Sustainable Rx Pricing, for which AHA is a founding member, today launched a petition and digital ad urging drug companies to suspend their “…
Headline
List prices for branded pharmaceutical products in the United States increased 159% between 2007 and 2018, an average of 9.1% per year, according to a study…
Headline
Four drugs used in hospitals for years increased their prices between 525% and 1,644% after receiving formal approval through the Food and Drug Administration’…
Headline
The Food and Drug Administration today approved the first generic albuterol sulfate inhaler to treat and prevent bronchospasms in patients with asthma or…
Headline
The Food and Drug Administration today released the first phase of its searchable Purple Book database, which includes all FDA-approved biosimilar and…
Headline
The House Ways and Means Health Subcommittee yesterday held a hearing on proposals to lower drug prices and promote new cures.  Witness Ge Bai, an…